Cover
Cover | 9 Months Ended |
Sep. 30, 2022 shares | |
Cover [Abstract] | |
Document Type | 10-Q |
Amendment Flag | false |
Document Quarterly Report | true |
Document Transition Report | false |
Document Period End Date | Sep. 30, 2022 |
Document Fiscal Period Focus | Q3 |
Document Fiscal Year Focus | 2022 |
Current Fiscal Year End Date | --12-31 |
Entity File Number | 000-55818 |
Entity Registrant Name | BioCrude Technologies USA, Inc. |
Entity Central Index Key | 0001690384 |
Entity Tax Identification Number | 81-2924160 |
Entity Incorporation, State or Country Code | NV |
Entity Address, Address Line One | 1255 Phillips Square |
Entity Address, Address Line Two | Suite 605 |
Entity Address, Address Line Three | Montreal |
Entity Address, City or Town | Quebec |
Entity Address, Country | CA |
Entity Address, Postal Zip Code | H3B 3G5 |
City Area Code | 514 |
Local Phone Number | 840-9719 |
Entity Current Reporting Status | No |
Entity Interactive Data Current | No |
Entity Filer Category | Non-accelerated Filer |
Entity Small Business | true |
Entity Emerging Growth Company | false |
Entity Shell Company | false |
Entity Common Stock, Shares Outstanding | 50,745,136 |
CONSOLIDATED BALANCE SHEETS (UN
CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 |
CURRENT ASSETS | ||
Cash | $ 745 | $ 1,778 |
Property, plant and equipment | 17,988 | 20,854 |
TOTAL ASSETS | 18,733 | 22,632 |
CURRENT LIABILITIES | ||
Accounts payable and accrued liabilities | 17,598 | 16,424 |
Accounts payable and accrued liabilities - related parties (Note 6) | 45,860 | 41,664 |
Loans payable (Note 4) | 148,882 | 138,394 |
TOTAL LIABILITIES | 212,340 | 196,482 |
STOCKHOLDERS’ DEFICIT | ||
Common stock, $0.001 par value, 75,000,000 shares authorized, 50,745,136 and outstanding (December 31, 2021 - 50,710,386) | 50,745 | 50,711 |
Additional paid in capital | 8,662,722 | 8,523,756 |
Accumulated other comprehensive income | 28,717 | 28,678 |
Deficit | (8,933,215) | (8,774,402) |
TOTAL STOCKHOLDERS’ DEFICIT ATTRIBUTALBLE TO EQUITY SHAREHOLDERS OF THE COMPANY | (191,031) | (171,257) |
NON-CONTROLLING INTEREST | (2,576) | (2,593) |
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | $ 18,733 | $ 22,632 |
CONSOLIDATED BALANCE SHEETS (_2
CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares | Sep. 30, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, authorized | 75,000,000 | 75,000,000 |
Common stock, issued | 50,745,136 | 50,710,386 |
Common stock, outstanding | 50,745,136 | 50,710,386 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Income Statement [Abstract] | ||||
REVENUE | $ 0 | $ 0 | $ 0 | $ 0 |
OPERATING EXPENSES | ||||
General and administrative | 88,296 | 45,880 | 155,870 | 360,733 |
Total operating expenses | 88,296 | 45,880 | 155,870 | 360,733 |
LOSS FROM OPERATIONS | (88,296) | (45,880) | (158,813) | (360,733) |
Interest expense | (964) | (1,000) | (2,943) | (3,126) |
Income tax expense | 0 | 0 | 0 | 0 |
NET LOSS | (89,260) | (46,880) | (158,813) | (363,859) |
OTHER COMPREHENSIVE LOSS | ||||
Exchange differences on translating foreign operations | (2) | (9) | (39) | 15 |
Exchange differences on translating non- controlling interest | (1) | (4) | (17) | 6 |
TOTAL COMPREHENSIVE LOSS | (89,257) | (46,867) | (158,757) | (363,838) |
NET LOSS ATTRIBUTABLE TO | ||||
Equity shareholders of the Company | (89,260) | (46,880) | (158,813) | (363,859) |
Non-controlling interest | 0 | 0 | 0 | 0 |
TOTAL COMPREHENSIVE LOSS ATTRIBUTABLE TO | ||||
Equity shareholders of the Company | (89,258) | (46,871) | (158,774) | (363,844) |
Non-controlling interest | $ 1 | $ (4) | $ 17 | $ 6 |
Net loss per common share basic and diluted | $ 0 | $ 0 | $ 0 | $ (0.01) |
Weighted average number of common shares outstanding basic and diluted | 50,720,239 | 50,650,850 | 50,720,239 | 50,650,850 |
CONSOLIDATED STATEMENTS OF CHAN
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | AOCI Attributable to Parent [Member] | Retained Earnings [Member] | Total Equity Attributable To Equity Shareholders Of The Company [Member] | Noncontrolling Interest [Member] | Total |
Beginning balance, value at Dec. 31, 2021 | $ 50,711 | $ 8,523,756 | $ 28,678 | $ (8,774,402) | $ (171,257) | $ (2,593) | $ (173,850) |
Beginning balance, shares at Dec. 31, 2021 | 50,710,386 | ||||||
Stock issued for services | |||||||
Subscription receivable | |||||||
Stock issued for cash | $ 12 | 49,998 | 50,000 | 50,000 | |||
Stock issued for cash, shares | 12,500 | ||||||
Foreign currency translation | 26 | 26 | 11 | 37 | |||
Net loss | (54,041) | (54,041) | (54,041) | ||||
Ending balance, value at Mar. 31, 2022 | $ 50,723 | 8,573,744 | 28,704 | (8,828,443) | (175,272) | (2,582) | (177,854) |
Ending balance, shares at Mar. 31, 2022 | 50,722,886 | ||||||
Stock issued for services | |||||||
Stock issued for cash | |||||||
Foreign currency translation | 11 | 11 | 5 | 16 | |||
Net loss | (15,512) | (15,512) | (15,512) | ||||
Ending balance, value at Jun. 30, 2022 | $ 50,723 | 8,573,744 | 28,715 | (8,843,955) | (190,773) | (2,577) | (193,350) |
Ending balance, shares at Jun. 30, 2022 | 50,722,886 | ||||||
Stock issued for services | $ 2 | 9,998 | 10,000 | 10,000 | |||
Stock issued for services, shares | 2,500 | ||||||
Stock issued for cash | $ 20 | 78,980 | 79,000 | 79,000 | |||
Stock issued for cash, shares | 19,750 | ||||||
Foreign currency translation | 2 | 2 | 1 | 3 | |||
Net loss | (89,260) | (89,260) | (89,260) | ||||
Ending balance, value at Sep. 30, 2022 | $ 50,745 | $ 8,662,722 | $ 28,717 | $ (8,933,215) | $ (191,031) | $ (2,576) | $ (193,607) |
Ending balance, shares at Sep. 30, 2022 | 50,745,136 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net loss | $ (158,813) | $ (363,859) |
Adjustments to reconcile net loss to net cash used in operating activities | ||
Accretion and interest expenses | 2,945 | 3,127 |
Amortization | 2,866 | 2,483 |
Stock issued for services | 10,000 | 186,198 |
Foreign exchange | (7,401) | (5,536) |
Changes in operating assets and liabilities | ||
Accounts payable and accruals | 1,174 | (17,966) |
Accounts payable and accrued liabilities – related party | 4,196 | (103,245) |
Net cash used in operating activities | (145,033) | (298,798) |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Proceeds from private placement | 129,000 | 220,000 |
(Repayment) Proceeds of loans payable | 15,000 | (12,835) |
Net cash provided by financing activities | 144,000 | 207,165 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Purchase of property, plant and equipment | 0 | (92) |
Net cash used in financing activities | 0 | (92) |
Effect of exchange rate changes on cash | 0 | 0 |
CHANGE IN CASH DURING THE PERIOD | (1,033) | (91,725) |
CASH BEGINNING | 1,778 | 109,971 |
CASH ENDING | 745 | 18,246 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||
Cash paid for income taxes | 0 | 0 |
Interest paid | $ 0 | $ 0 |
ORGANIZATION AND BASIS OF PRESE
ORGANIZATION AND BASIS OF PRESENTATION | 9 Months Ended |
Sep. 30, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION AND BASIS OF PRESENTATION | NOTE 1 ORGANIZATION AND BASIS OF PRESENTATION Nature of Operations Biocrude Technologies USA, Inc. (the “Company”) was incorporated under the laws of the State of Nevada on December 29, 2015. The Company’s principal business objective is to provide resource management expertise and services, catering to commercial, municipal, and industrial customers, primarily in the areas of solid waste management and recycling services. Interim Financial Statements The unaudited interim consolidated financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). They do not include all information and footnotes required by GAAP for complete financial statements. Except as disclosed herein, there have been no material changes in the information disclosed in the notes to the financial statements for the year ended December 31, 2021, included in the Company’s 2021 annual report on Form 10-K, filed with the SEC. The unaudited interim consolidated financial statements should be read in conjunction with those financial statements included in Form 10-K. In the opinion of management, all adjustments considered necessary for fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the nine-month period ended September 30, 2022, are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. Going Concern The Company’s consolidated financial statements are prepared on a going concern basis in accordance with United States generally accepted accounting principles (“US GAAP”) which contemplate the realization of assets and discharge of liabilities and commitments in the normal course of business. The Company has not generated operating revenues to date and has accumulated losses of $ 8,933,215 |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation and Principles of Consolidation These consolidated financial statements and related notes are presented in accordance with US GAAP and are presented in United States dollars. The accompanying consolidated financial statements include the accounts of its 100 Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant areas requiring management’s estimates and assumptions include determining the fair value of transactions involving shares common stock. Actual results could differ from those estimates. Fair Value Measurements The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The estimated fair value of certain financial instruments, including cash and cash equivalents, payables to related parties, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that be used to measure fair value: Level 1 - quoted prices in active markets for identical assets or Level 2 - quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 - inputs that are unobservable (for example cash flow modeling inputs based on assumptions) The Company’s financial assets and liabilities are subsequent measured at amortized cost, but their carrying amount approximates their fair value due to the short period of time until maturity. Foreign Currency Translation and Transaction The Company’s presentation currency is the U.S dollar. The functional currency of Biocrude USA and Biocrude HK is U.S dollar and Hong Kong dollar, respectively. Assets and liabilities of the foreign operations are translated to the U.S dollar using the exchange rate at period end, and income, expenses and cash flow items are translated using the rate approximates the exchange rates at the dates of the transactions (i.e., the average rate for the period). All resulting exchange differences recognized directly in other comprehensive income (loss). Transactions in currencies other than the entity’s functional currency are recorded at the rates of exchange prevailing at the dates of the transactions. At each statement of financial position date, monetary assets and liabilities are translated using the period end foreign exchange rate. Non-monetary assets and liabilities are translated using the historical rate on the date of the transaction. Non-monetary assets and liabilities that are stated at fair value are translated using the historical rate on the date that the fair value was determined. All gains and losses on translation of these foreign currency transactions are included in profit or loss. Cash and cash equivalents Cash and cash equivalents consist of cash balances and highly liquid instruments with an original maturity of three months or less. As at September 30, 2022 and 2021, the Company does no Property, plant and equipment Property, plant, and equipment are recorded at cost and depreciated to its estimated residual values using the straight-line method over its estimated useful lives of 8 Share-based Expense ASC 718, “ Compensation – Stock Compensation The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “ Equity – Based Payments to Non-Employees.” Income Taxes Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income for the years in which those differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income statement in the period that includes the date of enactment. Additionally, ASC 740: Income Taxes, requires the Company to recognize in its financial statements the impact of a tax position that is more likely than not to be sustained upon examination based on the technical merits of the position. Leases Effectively January 1, 2018, the Company adopted ASC Leases which requires a lessee to recognize the assets and liabilities that arise from leases, including operating leases. Under the new requirements, a lessee will recognize in the balance sheet a liability to make lease payments (the lease liability) and the right-of-use asset representing the right to the underlying asset for the lease term. For leases with a term of twelve months or less, the lessee is permitted to make an accounting policy election not to recognize lease assets and lease liabilities by class of underlying assets. The Company did not enter into any significant operating leases for the nine months period ended September 30, 2022 and did not have any significant leases as at December 31, 2021. Adoption of this standard does not have material impact on the Company’s interim consolidated financial statements. Earnings Per Share Information FASB ASC 260, “Earnings Per Share” provides for calculation of “basic” and “diluted” earnings per share. Basic earnings per share includes no dilution and is computed by dividing net loss available to common shareholders by the weighted average common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity similar to fully diluted earnings per share. Basic and diluted loss per share were the same, at the reporting dates, as there were no common stock equivalents outstanding. |
CONVERTIBLE NOTES
CONVERTIBLE NOTES | 9 Months Ended |
Sep. 30, 2022 | |
Debt Disclosure [Abstract] | |
CONVERTIBLE NOTES | NOTE 3 – CONVERTIBLE NOTES As at September 30, 2022, there are no |
LOANS PAYABLE
LOANS PAYABLE | 9 Months Ended |
Sep. 30, 2022 | |
Loans Payable | |
LOANS PAYABLE | NOTE 4 – LOANS PAYABLE As at September 30, 2022, the Company has loans payable of $ 116,123 110,026 32,759 29,814 4 December 31, 2022 15,000 25,336 |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 9 Months Ended |
Sep. 30, 2022 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 5 - RELATED PARTY TRANSACTIONS As at September 30, 2022, the “CEO” of the Company and a director had advanced the Company a cumulative $ 24,566 41,664 |
SHARE CAPITAL
SHARE CAPITAL | 9 Months Ended |
Sep. 30, 2022 | |
Equity [Abstract] | |
SHARE CAPITAL | NOTE 6 SHARE CAPITAL The Company is authorized to issue up to 75,000,000 0.001 50,745,136 50,710,386 |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 9 Months Ended |
Sep. 30, 2022 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 7 SUBSEQUENT EVENTS Subsequent to September 30, 2022, the Company issued 11,250 shares of the Company’s common stock for cash proceeds of $45,000 (October 6, 2022). Subsequent to September 30, 2022, the Company issued 1,125 shares of the Company’s common stock, with a fair value of $4,500, for services rendered (October 6, 2022). |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
Basis of presentation and Principles of Consolidation | Basis of presentation and Principles of Consolidation These consolidated financial statements and related notes are presented in accordance with US GAAP and are presented in United States dollars. The accompanying consolidated financial statements include the accounts of its 100 |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant areas requiring management’s estimates and assumptions include determining the fair value of transactions involving shares common stock. Actual results could differ from those estimates. |
Fair Value Measurements | Fair Value Measurements The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The estimated fair value of certain financial instruments, including cash and cash equivalents, payables to related parties, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that be used to measure fair value: Level 1 - quoted prices in active markets for identical assets or Level 2 - quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 - inputs that are unobservable (for example cash flow modeling inputs based on assumptions) The Company’s financial assets and liabilities are subsequent measured at amortized cost, but their carrying amount approximates their fair value due to the short period of time until maturity. |
Foreign Currency Translation and Transaction | Foreign Currency Translation and Transaction The Company’s presentation currency is the U.S dollar. The functional currency of Biocrude USA and Biocrude HK is U.S dollar and Hong Kong dollar, respectively. Assets and liabilities of the foreign operations are translated to the U.S dollar using the exchange rate at period end, and income, expenses and cash flow items are translated using the rate approximates the exchange rates at the dates of the transactions (i.e., the average rate for the period). All resulting exchange differences recognized directly in other comprehensive income (loss). Transactions in currencies other than the entity’s functional currency are recorded at the rates of exchange prevailing at the dates of the transactions. At each statement of financial position date, monetary assets and liabilities are translated using the period end foreign exchange rate. Non-monetary assets and liabilities are translated using the historical rate on the date of the transaction. Non-monetary assets and liabilities that are stated at fair value are translated using the historical rate on the date that the fair value was determined. All gains and losses on translation of these foreign currency transactions are included in profit or loss. |
Cash and cash equivalents | Cash and cash equivalents Cash and cash equivalents consist of cash balances and highly liquid instruments with an original maturity of three months or less. As at September 30, 2022 and 2021, the Company does no |
Property, plant and equipment | Property, plant and equipment Property, plant, and equipment are recorded at cost and depreciated to its estimated residual values using the straight-line method over its estimated useful lives of 8 |
Share-based Expense | Share-based Expense ASC 718, “ Compensation – Stock Compensation The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “ Equity – Based Payments to Non-Employees.” |
Income Taxes | Income Taxes Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income for the years in which those differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income statement in the period that includes the date of enactment. Additionally, ASC 740: Income Taxes, requires the Company to recognize in its financial statements the impact of a tax position that is more likely than not to be sustained upon examination based on the technical merits of the position. |
Leases | Leases Effectively January 1, 2018, the Company adopted ASC Leases which requires a lessee to recognize the assets and liabilities that arise from leases, including operating leases. Under the new requirements, a lessee will recognize in the balance sheet a liability to make lease payments (the lease liability) and the right-of-use asset representing the right to the underlying asset for the lease term. For leases with a term of twelve months or less, the lessee is permitted to make an accounting policy election not to recognize lease assets and lease liabilities by class of underlying assets. The Company did not enter into any significant operating leases for the nine months period ended September 30, 2022 and did not have any significant leases as at December 31, 2021. Adoption of this standard does not have material impact on the Company’s interim consolidated financial statements. |
Earnings Per Share Information | Earnings Per Share Information FASB ASC 260, “Earnings Per Share” provides for calculation of “basic” and “diluted” earnings per share. Basic earnings per share includes no dilution and is computed by dividing net loss available to common shareholders by the weighted average common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity similar to fully diluted earnings per share. Basic and diluted loss per share were the same, at the reporting dates, as there were no common stock equivalents outstanding. |
ORGANIZATION AND BASIS OF PRE_2
ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Accumulated losses | $ 8,933,215 | $ 8,774,402 |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Cash equivalents | $ 0 | $ 0 |
Estimated useful lives | 8 years | |
Biocrude H K [Member] | ||
Noncontrolling Interest, Ownership Percentage by Parent | 100% |
CONVERTIBLE NOTES (Details Narr
CONVERTIBLE NOTES (Details Narrative) | Sep. 30, 2022 USD ($) |
Debt Disclosure [Abstract] | |
Convertible loans | $ 0 |
LOANS PAYABLE (Details Narrativ
LOANS PAYABLE (Details Narrative) - USD ($) | 9 Months Ended | |
Sep. 30, 2022 | Dec. 31, 2021 | |
Short-Term Debt [Line Items] | ||
Loans Payable | $ 116,123 | $ 110,026 |
Interest Payable, Current | 32,759 | 29,814 |
Director [Member] | ||
Short-Term Debt [Line Items] | ||
Loans Payable | $ 15,000 | $ 25,336 |
Loans Payable [Member] | ||
Short-Term Debt [Line Items] | ||
Interest rate | 4% | |
Maturity date | Dec. 31, 2022 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) | 9 Months Ended | 12 Months Ended |
Sep. 30, 2022 | Dec. 31, 2021 | |
Chief Executive Officer [Member] | ||
Related Party Transaction [Line Items] | ||
Advances from related parties | $ 24,566 | $ 41,664 |
SHARE CAPITAL (Details Narrativ
SHARE CAPITAL (Details Narrative) - $ / shares | Sep. 30, 2022 | Dec. 31, 2021 |
Equity [Abstract] | ||
Common stock, authorized | 75,000,000 | 75,000,000 |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, issued | 50,745,136 | 50,710,386 |
Common stock, outstanding | 50,745,136 | 50,710,386 |